Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News DiaMedica Therapeutics Inc DMAC

Healthcare Biotechnology
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:DMAC)

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results

Business Wire 8 days ago

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia

Business Wire 8 days ago

DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference

Business Wire 10 days ago

DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024

Business Wire November 6, 2024

DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia

Business Wire October 9, 2024

DiaMedica Therapeutics Upcoming Conference Participation

Business Wire September 4, 2024

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results

Business Wire August 7, 2024

DiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024

Business Wire August 1, 2024

DiaMedica Therapeutics Releases Preeclampsia White Paper and Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia

Business Wire July 11, 2024
View More News ››

Opinion & Analysis (NDAQ:DMAC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:DMAC)

DiaMedica Therapeutics Inc. (DMAC): Navigating the Challenge

http://beyondspx.com/2024/08/02/diamedica-therapeutics-inc-dmac-navigating-the-challenges-of-advancing-a-promising-stroke-treatment/
MikeTester - August 3, 2024

DiaMedica Therapeutics Announces $11.8 Million Private Place

BREAKING NEWS: $DMAC DiaMedica Therapeutics Announces $11.8 Million Private PlacementDiaMedica Therapeutics Inc. (Nasdaq: DMAC), a...
whytestocks - June 26, 2024

Here is something to think about to diversify.

Aristotle - 10 Cancers - One Sample of Blood Unlimited Possibilities. It's on the Toronto Stock Exchange in Canada. QR is about to be...
StockscoutX - February 3, 2021

C'mon Jinxmom

you spinless loser...enjoy your cr@p life...end it....we are having fun! 
TradeSaver2 - November 10, 2020

DiaMedica Therapeutics to Present at Conference

DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020 Link
StockscoutX - September 15, 2020

DiaMedica Announces First Patients Dosed

DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study Link
StockscoutX - September 15, 2020
View more Bullboard ››

Desert Gold Ventures Inc.

Desert Gold Ventures Inc.

Desert Gold Ventures Inc. is a gold exploration and development company which controls the approximately 440 square ...
View More »